IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. (Q53670887)

17 May 2018

title

IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. (English)

1 reference

17 May 2018

author name string

Charles A O'Brien

1

1 reference

17 May 2018

Robert L Jilka

2

1 reference

17 May 2018

Qiang Fu

3

1 reference

17 May 2018

Scott Stewart

4

1 reference

17 May 2018

Robert S Weinstein

5

1 reference

17 May 2018

Stavros C Manolagas

6

1 reference

17 May 2018

publication date

14 June 2005

1 reference

17 May 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

17 May 2018

volume

289

1 reference

17 May 2018

issue

5

1 reference

17 May 2018

page(s)

E784-93

1 reference

17 May 2018

Expression of a foreign gene in a line of transgenic mice is modulated by a chromosomal position effect

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

In VivoEvidence for the Intermediary Role of 3′,5′-Cyclic AMP in Parathyroid Hormone-Induced Stimulation of lα,25-Dihydroxy vitamin D3Synthesis in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Reversal of bone loss in mice by nongenotropic signaling of sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroi

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Effect of interleukin-6 secreted by engineered human stromal cells on osteoclasts in human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Functionin Vivoandin Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

In vivo administration of 1,25‐dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

The mechanical strength of femurs of rats and mice fed a calcium-deficient diet—A differential species response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00029.2005

10.1152/AJPENDO.00029.2005

21 January 2018

Identifiers

DOI

1 reference

17 May 2018

PubMed ID

15956054

1 reference

17 May 2018